Epilepsy12 Aims
 To facilitate health providers and commissioners to measure and improve quality of care for children and young people with seizures and epilepsies  To contribute to the continuing improvement of outcomes for those children, young people and their families
Audit structure and engagement  The UK has already been divided into 17 established Organisation of Paediatric Epilepsy Networks in the United Kingdom (OPEN UK) regions and national clinical networks, each with a defined link/lead person  Each region is divided into relevant Health Boards/Trusts* with a defined 'link paediatrician' lead for Epilepsy12. Some Trusts may wish to delegate OPEN UK and Epilepsy12 roles separately  Relevant Trusts are those within the UK comprising a paediatric service providing initial care and/or ongoing care for children with seizures and/or epilepsies  Registration and reporting of results will be at a Trust-wide level only but some larger
Trusts may choose to view patient data and results at a 'sub-Trust' granularity reflecting separately functioning epilepsy services and the Epilepsy12 data system will allow for this  Each relevant Trust will register with Epilepsy12  Defined Trusts will have unique permissions within the audit data platform  Defined paediatricians, epilepsy specialist nurses and other professionals will have unique functionality, permissions and roles within their Trust's access on the data platform *For ease of reference the term "Trust" will be used throughout the remainder of this document, however the Epilepsy12 Project Team recognises that participation in the audit will be by "Health Boards" in Scotland and Wales and "Trusts" in England.
**Where the term "UK" is used throughout this document this refers to England, Scotland and Wales. This is due to the fact that at the start of the Epilepsy12 Round 3 contract in April 2017, information governance arrangements relating to the release of patient data outside of Northern Ireland meant that it was not possible for the 6 Health and Social Care (HSC) Trusts in Northern Ireland to participate.
Map of the 17 OPEN UK regional and national paediatric epilepsy clinical networks
Schemata showing the proposed structural alignment of OPEN UK paediatric epilepsy networks with relevant component Trusts participating in Epilepsy12: 
Epilepsy12 Round 3 Components
The audit will be comprised of 3 audit domains:
 Service descriptor domain (Organisational Audit)  Clinical care domain  Patient Reported Experience Measures (PREM) domain
The Epilepsy12 audit domains will align to each participating Trust within OPEN UK networks
Domains will be mapped to participating Trusts at relevant points in time throughout the ongoing audit. The Epilepsy 12 Rounds 3+ Reporting Timeline diagram on page 22 shows how data for the domains will be collected sequentially and analysed and reported on over time.
The work of the project started on 1 April 2017 so the first service descriptor "census day" and the start of data collection for first paediatric assessments for the clinical care domain for the initial yearly cohort ("day 0") will commence on 1 April 2018.
Service descriptor domain (Organisational Audit)
Each relevant Trust will complete a yearly service descriptor dataset describing their Trust's current epilepsy service. Live updates (for example service improvements, changes to staff workforce or reconfigurations) can be made to this ongoing dataset but all questions must be answered by a defined closing date for a submission for each yearly 'census day.'
Clinical care domain
Defined children and their ongoing care will be captured within the Epilepsy12 audit.
Clinical Cohort Ascertainment
Epilepsy12 will aim to include all UK children under the care of a paediatric service with suspected epilepsy with a first paediatric assessment from "day 0" (proposed as 1 April 2018) with ongoing audit of those with diagnosed epilepsy. 
Initial patient registration
Initial registration will be possible from different individuals and services via the web platform. This initial heterogeneous and non-specific group will be identified principally from both the referring clinical team and EEG services who will be facilitated to register via the Epilepsy12 platform all children and young people referred by a paediatric service for a first EEG after Epilepsy12 Day 0. The initial registration processes will check against the patient's NHS/CHI number to ensure no duplication of individual patients.
The initial registration dataset will cover the following details:  Confirmation that it is a NHS patient, not private  Referral made by a paediatric service rather than adult service  Confirmation no previous EEGs 
Trust verification
All children meeting initial registration validation criteria will then be listed for 'Trust verification' by the referring Trust. This phase is about adding key confirmatory information in different ways. For example, case notes may not need to be pulled to include some children e.g. some services may be able to confirm inclusions for some children by review of electronic records.
Trust verification on the Epilepsy12 system will cover the following:
 Whether the child had a paroxysmal episode or episodes prompting first paediatric assessment  Confirmation of the date on which the very first paediatric assessment for the episode or episodes occurred  Whether the patient had previous EEG or first paediatric assessment for similar episodes or episodes or epilepsy  Date of the EEG if first EEG achieved  Initial home postcode
Validation Criteria for next steps
 Confirmation that the parents or young person have not requested opt out at any time  The child has had a paroxysmal episode or episodes prompting a first paediatric assessment.  Young people referred for EEG by an adult service, or who had a first adult assessment or non-NHS service EEG or first assessment would not be included  The date of 'First paediatric assessment' for the 'paroxysmal episode or episodes' must have occurred after Epilepsy12 day 0 (1 April 2018)  The patient has not had a first paediatric assessment previously for a similar episode or episodes or epilepsy prior to first paediatric assessment AND prior to Epilepsy12 day 0. In this situation, it would be the original first assessment that counts. If they had a paediatric assessment previously after day 0, and had not been registered for whatever reason, then the child's very first assessment is the key verification date that should be entered  Children where the verification criteria are not determined or are not determinable (e.g. notes not available or unclear labelled as not done/uncertain) will not be included. The non-inclusion of such children will be reflected in a reduced ascertainment completeness. 
Verified Patients
Each child identified as verified for inclusion by the referring Trust will be added to a platform worklist for the relevant Trust. The patient data will be submitted by defined times after the first paediatric assessment and each subsequent year. Times will be determined by the individual patient's first paediatric assessment date and by key annual audit dates, for example census day 0. Data will updatable via a 'Live Update' functionality within the system. Data will be obtained by a series of predominantly mandatory questions to be completed after the first paediatric assessment, in the 12 months after the first paediatric assessment and after subsequent yearly reviews until the patient achieves a defined 'exit' from the audit. Questions and 'exit' parameters are listed in dataset section.
Diagnostic status dataset
Diagnostic status will be a key dataset item determined at ongoing points in time to confirm those children having achieved a diagnosis of epilepsy.
The following table illustrates the way that diagnostic status can considered at the defined points in time and that some children may have a mixture of types of episodes that are considered as uncertain initially but later become diagnosed as non-epileptic or epileptic episodes. 
Epilepsy confirmation and ongoing auditing
Children whose updated diagnostic status at any time is '2 or more epileptic episodes' or 'considered as having epilepsy for other reason' at any time will be deemed as eligible for the clinical audit datasets (as summarised in the datasets macro diagram). Children with a diagnostic status that does not include epilepsy will not have full auditing datasets required at that point in time.
The following table illustrates the different points in time when ongoing audit data will be captured by the Epilepsy12 platform. 
Audit dataset Completed by

Focus of questions
Ascertainment and auditing worklists
Initial registration, Trust verification, ongoing Trust and follow up status, diagnostic status confirmation and ongoing auditing will be supported by live dashboard and worklists.
Diagram showing the ascertainment and audit processes:
Due to the operational complexity of the ongoing ascertainment process and need to work closely with the platform developers, the following diagram is provisional and may be changed during platform build and testing. 
Ascertainment and data completeness
Will be reported at Trust, regional, national and UK levels for each audit year:
External ascertainment completeness Epilepsy12 new epilepsy diagnoses for given audit year and defined age group/estimated new epilepsy diagnoses based on population and published incidence data Epilepsy12 first EEG in audit year/HES first EEG procedure codes for audit year Internal Ascertainment completeness (A+B)/C for referring Trust First paediatric assessment data completeness = X completed/Y and relevant Trust at first paediatric assessment First year data completeness = V completed/Y and relevant Trust at 1 year
Participation completeness
The degree of audit participation that will be reported for all UK secondary paediatric service health providers
Data completeness
Number of children with completed data entry for submission stage each year/ total number of verified children at each submission stage each year
PREM domain
The PREM questionnaire from Round 2 is currently being validated. The previous methodology included a paper-based questionnaire being handed out to consecutive families with epilepsy attending clinics and completed in the waiting area before clinic review. Forms were handed in and anonymously analysed centrally by the project team and reported. The PREM for rounds 3+ will be based on an updated and validated PREM dataset which will be developed in conjunction with engagement activities led by the RCPCH Children and Young People's Engagement team. This will be introduced in year 3 of the project timeline after the first yearly patient cohort has completed 12 months of care following their first paediatric assessment. The dataset and methodology for this domain is not currently finalised.
Epilepsy 12 Clinical Performance Indicators
There will be 12 defined performance indicators derived from national guidelines and recommendations with a defined percentage score.
Some performance indicators are applied to those children who are newly diagnosed with epilepsy within a specific audit year. Some performance indicators are cumulative and apply to all ongoing children with epilepsy in each audit yearly cohort.
The Epilepsy12 audit will provide Live Dashboard reporting outputs for users at a Trust provider level and will then produce annual reports of analysis of data at Trust, Regional, National and UK levels which will be made available in the public domain.
 Each performance indicator (PI) is mapped to the relevant SIGN recommendation*, NICE guideline recommendations, NICE quality standards or other national recommendations. *The 2005 SIGN guidelines are no longer active and their review is pending.  Each PI has a defined method of calculation, numerator and denominator.  For each PI 100% is the maximum 'score'. However, it may not be optimal for a service to score 100% as patients and circumstances differ and not all children fit with all models of care. PIs are designed such that the 100% end of the scale represents better care rather than 0%  'League tables' remain considered as an inappropriate and non-meaningful approach to displaying results.  Individual Trust's scores will be shown alongside others (e.g. in a funnel plot type representation) in Epilepsy12 public facing yearly annual reports  There may be a few larger Trusts where additional epilepsy service reporting is offered in addition to other reporting levels but only within the data system itself for the purpose of local, internal reporting in support of service improvement  Interpretation should be guided by knowledge of ascertainment methods and composition of the cohorts of children and the methodological limitations of retrospective case-note analysis.  In some cases, the performance indicator is looking for internal consistency within the diagnosis / management rather than objectively assessing management. For example, MRI is deemed 'appropriate' if the assessor diagnoses epileptic seizures under 2 years; the 'correctness' of this diagnosis however is not ratified by the audit process i.e. if the diagnosis was incorrect (e.g. non-epileptic) MRI may not have been indicated. Numerator = Number of children less than 2 years old at first assessment with a diagnosis of epilepsy at first year OR children with a diagnosis of epilepsy at first year who are NOT JME or JAE or CAE or CECTS/Rolandic AND who had an MRI Denominator = Number of children less than 2 years old at first assessment with a diagnosis of epilepsy at first year OR children with a diagnosis of epilepsy at first year who are NOT JME or JAE or CAE or BECTS/Rolandic Management and outcome 8
Epilepsy12 Clinical Performance Indicators
Accuracy of diagnosis
Percentage of children diagnosed with epilepsy, who still had that diagnosis at 1 year AED therapy should only be started once the diagnosis of epilepsy is confirmed, except in exceptional circumstances that require discussion and agreement between the prescriber, the specialist and the individual and their family and/or carers as appropriate.
n/a n/a (criteria within Epilepsy12 methodology are simplified to children < 2 years and children with 3 or more AEDs or fulfilling CESS criteria; timeliness of referral not currently captured)
Epilepsy12
Dataset rounds 3+ will also include metrics to encompass the following NICE Quality Standards: Statement 1. Children and young people presenting with a suspected seizure are seen by a specialist in the diagnosis and management of the epilepsies within 2 weeks of presentation. Statement 2. Children and young people having initial investigations for epilepsy undergo the tests within 4 weeks of them being requested. Statement 8. Children and young people with epilepsy have a structured review with a paediatric epilepsy specialist at least annually. Statement 9. Young people with epilepsy have an agreed transition period during which their continuing epilepsy care is reviewed jointly by paediatric and adult services.
Best Practice Criteria (BPC) 2019/20
 BPC criteria are applicable to England only.  BPC elements will be built into the Epilepsy12 web platform Live Dashboard area for audit users with an ability for all to view and download related quarterly reports  BPC adherence will be published at Trust level  BPC adherence will be reported for the whole of the UK (notwithstanding the fact that Northern Ireland is not participating as at the start of the project) including nations where the best practice tariff is not implemented The Epilepsy12 dataset and reporting outputs may be updated to align with the best practice tariff as and when it is amended and agreed. The agreed 2019/20 best practice tariff criteria and wording will be informed such that they can be captured where possible within the ongoing Epilepsy12 dataset and methodology.
